1. Objective To study ultrastructural changes of endometrial carcinoma.

2. Endometrial carcinoma is one of the most common three malignancies of female's reproductive system.

3. Conclusions: Elf - 1 expression in endometrial carcinoma correlates with the malignant potential of this tumor.

4. Methods: ER and PR of 32 cases of endometrial carcinoma were measured by immunohistochemical method.

5. Results The incidence of endometrial carcinoma occurred following pelvic irradiation was 0.19 %.

6. Bankground: Endometrial carcinoma ( EC ) is a kind of malignancies derived form endometria.

7. But no association between the pathology characters endometrial carcinoma and the digested polymorphism.

8. This case of Japanese big - ear rabbIt'spontaneous endometrial carcinoma is adenocarcinoma.

9. Objective To discuss the in vitro killing effect of injecting paclitaxel liposome on endometrial carcinoma.

10. Objective : To retrospectively analyze the clinical characteristics and outcomes of endometrial carcinoma ( EC ) in postmenopausal patients.

11. Objective : To study the relationship between the expression of hMLH _ 1 and endometrial carcinoma.

12. Objective : To study the role of cell kinetics in the mechanism of endometrial carcinoma.

13. VBT should be the adjuvant treatment of choice for patients with endometrial carcinoma of high - intermediate risk.

14. Enhanced expression of Elf - 1 has been reported in prostate cancer 、 endometrial carcinoma and osteosarcoma.

15. Objective: To investigate the relationship between the transcriptional expression of RASSF1A(Ras association domain family 1A gene) and oncogenesis and the development of endometrial carcinoma.

16. Objective To study synchronous or metachronous multiple primary malignant tumors (MPMT) in patients with endometrial carcinoma.

17. Objective To study the effects of angiogenesis on the development of endometrial carcinoma.

18. Objective To study the expression of thymidine phosphorylase in endometrial carcinoma and angiogenesis and its correlation with clinicopathologic features.

19. Methods The expression of FHIT and PCNA protein in 10 normal endometria, 16 endometrial atypical hyperplasia and 44 endometrial carcinoma tissues was observed by immunohistochemical S-P method.

20. AIM : To investigate endocrine differentiation and its mechanism in endometrial carcinoma.

21. MVD is correlated with tumor malignancy, infiltration and metastasis, and can be used as an important prognosticator of endometrial carcinoma.

22. Objective To study the relationship between serum CA 125 level and prognosis of uterine endometrial carcinoma.